@article{TLCR25847,
author = {Alessandro Inno and Anna Stagno and Stefania Gori},
title = {Schlafen-11 (SLFN11): a step forward towards personalized medicine in small-cell lung cancer?},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 4},
year = {2018},
keywords = {},
abstract = {Small-cell lung cancer (SCLC) is a highly aggressive disease with dismal prognosis (1). Given its tendency to early develop widespread metastases, in approximatively two-thirds of cases SCLC is diagnosed at extensive-stage (ES). Standard treatment for ES-SCLC has remained unchanged for years.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/25847}
}